New York Life Investment Management’s Cognizant CTSH Stock Holding History
Bought
Maintained
Sold
Other funds holding CTSH
New York Life Investment Management's CTSH Position: Q2 2026 in Review
New York Life Investment Management reduced its Cognizant (CTSH) stake by 0.64% in Q2 2026, selling an estimated $23.9K and leaving 70,550 shares worth $2.73M. The position accounts for 0.02% of the portfolio, ranked #498.
New York Life Investment Management first reported a position in CTSH in Q2 2022 and has held it in 17 quarters since. The position peaked at $8.06M in Q2 2023. 679 funds tracked by Wall St. Rank hold CTSH as of Q2 2026.
- New York Life Investment Management held 70,550 shares of Cognizant worth $2.73M as of Q2 2026.
- New York Life Investment Management sold 454 Cognizant shares in Q2 2026, an estimated $23.9K.
- Cognizant made up 0.02% of New York Life Investment Management's portfolio in Q2 2026, its #498 holding.
- New York Life Investment Management first reported a position in Cognizant in Q2 2022 and has held it in 17 quarters since.
- New York Life Investment Management's Cognizant position peaked at $8.06M in Q2 2023.
- 679 funds tracked by Wall St. Rank held Cognizant as of Q2 2026.
Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.